Literature DB >> 25110765

Noninvasive assessment of liver steatosis using ultrasound methods.

Monica Lupşor-Platon1, Horia Stefănescu2, Daniel Mureșan3, Mira Florea4, Mária Erzsébet Szász5, Anca Maniu5, Radu Badea5.   

Abstract

Hepatic steatosis is a condition frequently encountered in clinical practice, with potential progression towards chirrhosis and hepatocellular carcinoma. Ultrasonography (US) is one of the noninvasive imaging techniques used in the diagnosis of steatosis. We will review the US diagnostic criteria, the US performance in the diagnosis and grading of hepatic steatosis, the US steatosis models, but also its limitations in the diagnosis of steatosis. In addition, we will discuss 2 modern methods of assessing hepatic steatosis using ultrasounds, namely the computerized processing of data forming the US image and the controlled attenuation parameter measured with unidimensional transient elastography.

Entities:  

Mesh:

Year:  2014        PMID: 25110765     DOI: 10.11152/mu.2013.2066.163.1mlp

Source DB:  PubMed          Journal:  Med Ultrason        ISSN: 1844-4172            Impact factor:   1.611


  21 in total

1.  Ultrasonographic Nonalcoholic Fatty Pancreas Is Associated with Advanced Fibrosis in NAFLD: A Retrospective Analysis.

Authors:  Russell Rosenblatt; Amit Mehta; David Snell; Erika Hissong; Andrea Siobhan Kierans; Sonal Kumar
Journal:  Dig Dis Sci       Date:  2018-09-29       Impact factor: 3.199

Review 2.  Controversy in the diagnosis of pediatric non-alcoholic fatty liver disease.

Authors:  Pierluigi Marzuillo; Anna Grandone; Laura Perrone; Emanuele Miraglia Del Giudice
Journal:  World J Gastroenterol       Date:  2015-06-07       Impact factor: 5.742

3.  Dysregulation of the Splicing Machinery Is Associated to the Development of Nonalcoholic Fatty Liver Disease.

Authors:  Mercedes Del Río-Moreno; Emilia Alors-Pérez; Sandra González-Rubio; Gustavo Ferrín; Oscar Reyes; Manuel Rodríguez-Perálvarez; Marina E Sánchez-Frías; Rafael Sánchez-Sánchez; Sebastián Ventura; José López-Miranda; Rhonda D Kineman; Manuel de la Mata; Justo P Castaño; Manuel D Gahete; Raúl M Luque
Journal:  J Clin Endocrinol Metab       Date:  2019-08-01       Impact factor: 5.958

4.  Accuracy of Liver Fat Quantification With Advanced CT, MRI, and Ultrasound Techniques: Prospective Comparison With MR Spectroscopy.

Authors:  Harald Kramer; Perry J Pickhardt; Mark A Kliewer; Diego Hernando; Guang-Hong Chen; James A Zagzebski; Scott B Reeder
Journal:  AJR Am J Roentgenol       Date:  2016-10-11       Impact factor: 3.959

5.  Anxiety and Depression in Metabolic-Dysfunction-Associated Fatty Liver Disease and Cardiovascular Risk.

Authors:  Abdulrahman Ismaiel; Mihail Spinu; Daniel-Corneliu Leucuta; Stefan-Lucian Popa; Bogdan Augustin Chis; Mihaela Fadgyas Stanculete; Dan Mircea Olinic; Dan L Dumitrascu
Journal:  J Clin Med       Date:  2022-04-28       Impact factor: 4.964

6.  Non-invasive Testing for NASH and NASH with Advanced Fibrosis: Are We There Yet?

Authors:  Ahilan Arulanandan; Rohit Loomba
Journal:  Curr Hepatol Rep       Date:  2015-04-22

7.  Diagnostic Accuracy of Controlled Attenuation Parameter for Detecting Hepatic Steatosis in Patients with Chronic Liver Disease.

Authors:  Patrícia Andrade; Susana Rodrigues; Eduardo Rodrigues-Pinto; Rui Gaspar; Joanne Lopes; Susana Lopes; Guilherme Macedo
Journal:  GE Port J Gastroenterol       Date:  2016-12-23

8.  Pancreatic Steatosis Is Associated with Both Metabolic Syndrome and Pancreatic Stiffness Detected by Ultrasound Elastography.

Authors:  Orhan Sezgin; Serkan Yaraş; Osman Özdoğan
Journal:  Dig Dis Sci       Date:  2021-03-02       Impact factor: 3.199

Review 9.  Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives.

Authors:  Szu-Yi Liu; I-Ting Tsai; Yin-Chou Hsu
Journal:  Int J Mol Sci       Date:  2021-05-13       Impact factor: 5.923

Review 10.  Epidemiology of Alcohol-Associated Liver Disease.

Authors:  Sen Han; Zhihong Yang; Ting Zhang; Jing Ma; Kristina Chandler; Suthat Liangpunsakul
Journal:  Clin Liver Dis       Date:  2021-05-26       Impact factor: 6.265

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.